Strong Hearts for New York: A Rural Heart Disease Prevention Study
NCT ID: NCT03059472
Last Updated: 2022-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
182 participants
INTERVENTIONAL
2017-03-31
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strong Hearts: Rural CVD Prevention
NCT02499731
Reducing Cardiovascular Disease Risk Factors in Rural Communities in North Carolina
NCT02707432
StrongWomen- Healthy Hearts: A Community Based Program for Midlife and Older Women
NCT01439477
Heart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) Risk
NCT01245686
Preventative Screening and Health Coaching in a Food Insecure Population
NCT06907524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
RANDOMIZED INTERVENTION AND DELAYED INTERVENTION: In the current phase of the project, the efficacy of the SHHC program curriculum will be evaluated in a 24-week delayed intervention trial. The investigators will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed communities in New York State. In addition, changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network" will be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (Intervention)
Full Intervention participants will meet twice per week for one hour each time, for approximately 6 months. Participants will learn and practice good nutrition and physical activity for improved individual, family and community health.
Group 1 (Intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Group 2 (Delayed intervention)
Delayed intervention participants will participate in the same activities as Group 1 but 6 months after Group 1.
Group 2 (Delayed intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1 (Intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Group 2 (Delayed intervention)
The investigators will evaluate the efficacy of the SHHC curriculum in a 24-week community-based randomized delayed intervention trial. They will compare changes in CVD-related anthropometric, physiologic, behavioral, and psychosocial parameters between subjects in 5 intervention and 6 delayed intervention communities. In addition, the investigators will evaluate changes in behavior, attitudes, and knowledge among SHHC intervention subjects' "social network".
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* If BMI is less than 30, not currently physically active
* Blood pressure is less than 160/100 mm Hg
* Heart rate is between 60-100 bpm
* English-speaking
* Able and willing to obtain physician's approval to participate in intervention starting either in March 2017 or September 2017
* Willing to participate in assessment activities
* Willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017
Exclusion Criteria
* If BMI is less than 30, currently physically active
* Untreated hypertension
* Heart rate lower than 60 or higher than 100 bpm
* Non-English speaking
* Not able or willing to obtain physician's approval to participate
* Not interested or willing to participate in assessment activities
* Not able or willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017
40 Years
99 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montana State University
OTHER
Tufts University
OTHER
Bassett Healthcare
OTHER
Cornell Cooperative Extension
UNKNOWN
Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Seguin, PhD
Role: PRINCIPAL_INVESTIGATOR
Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clyde
Clyde, New York, United States
Cobleskill
Cobleskill, New York, United States
Cooperstown
Cooperstown, New York, United States
Dolgeville and Little Falls
Dolgeville, New York, United States
Hamilton
Hamilton, New York, United States
Hartwick
Hartwick, New York, United States
Herkimer, Mohawk and Ilion
Herkimer, New York, United States
Ithaca
Ithaca, New York, United States
Seguin Research Lab, Cornell University
Ithaca, New York, United States
Milford
Milford, New York, United States
Morrisville
Morrisville, New York, United States
Newark
Newark, New York, United States
Sharon Springs
Sharon Springs, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Andreyeva E, Graham ML, Eldridge GD, Folta SC, Nelson ME, Strogatz D, Seguin-Fowler RA. Cost-Effectiveness of Two Iterations of a Community-Based Cardiovascular Disease Prevention Intervention. Obesity (Silver Spring). 2025 Oct 16. doi: 10.1002/oby.70050. Online ahead of print.
Szeszulski J, Rolke LJ, Ayine P, Bailey R, Demment M, Eldridge GD, Folta SC, Graham ML, MacMillan Uribe AL, McNeely A, Nelson ME, Pullyblank K, Rethorst C, Strogatz D, Seguin-Fowler RA. Process evaluation findings from Strong Hearts, Healthy Communities 2.0: a cardiovascular disease prevention intervention for rural women. Int J Behav Nutr Phys Act. 2024 Oct 22;21(1):122. doi: 10.1186/s12966-024-01670-y.
MacMillan Uribe AL, Demment M, Graham ML, Szeszulski J, Rethorst CD, Githinji P, Nelson ME, Strogatz D, Folta SC, Bailey RL, Davis JN, Seguin-Fowler RA. Improvements in dietary intake, behaviors, and psychosocial measures in a community-randomized cardiovascular disease risk reduction intervention: Strong Hearts, Healthy Communities 2.0. Am J Clin Nutr. 2023 Nov;118(5):1055-1066. doi: 10.1016/j.ajcnut.2023.09.003. Epub 2023 Sep 17.
Maddock JE, Demment M, Graham M, Folta S, Strogatz D, Nelson M, Ha SY, Eldridge GD, Seguin-Fowler RA. Changes in physical activity outcomes in the Strong Hearts, Healthy Communities (SHHC-2.0) community-based randomized trial. Int J Behav Nutr Phys Act. 2022 Dec 28;19(1):159. doi: 10.1186/s12966-022-01401-1.
Seguin-Fowler RA, Eldridge GD, Rethorst CD, Graham ML, Demment M, Strogatz D, Folta SC, Maddock JE, Nelson ME, Ha S. Improvements and Maintenance of Clinical and Functional Measures Among Rural Women: Strong Hearts, Healthy Communities-2. 0 Cluster Randomized Trial. Circ Cardiovasc Qual Outcomes. 2022 Nov;15(11):e009333. doi: 10.1161/CIRCOUTCOMES.122.009333. Epub 2022 Nov 15.
Seguin-Fowler RA, Strogatz D, Graham ML, Eldridge GD, Marshall GA, Folta SC, Pullyblank K, Nelson ME, Paul L. The Strong Hearts, Healthy Communities Program 2.0: An RCT Examining Effects on Simple 7. Am J Prev Med. 2020 Jul;59(1):32-40. doi: 10.1016/j.amepre.2020.01.027. Epub 2020 May 7.
Pullyblank K, Strogatz D, Folta SC, Paul L, Nelson ME, Graham M, Marshall GA, Eldridge G, Parry SA, Mebust S, Seguin RA. Effects of the Strong Hearts, Healthy Communities Intervention on Functional Fitness of Rural Women. J Rural Health. 2020 Jan;36(1):104-110. doi: 10.1111/jrh.12361. Epub 2019 Mar 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB #: 1402004505-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.